Immunotherapy of cancer patients with BCG: summary of ten years experience in Japan.
Two thousand and four patients with various types of late stage cancer were treated with living BCG immunotherapy from 1972 to 1982. Fourty-five out of 1,112 patients were able to survive more than 5 years after initiation of this immunotherapy. All of these patients were noncurative operation except for 2 cases of hepatoma who received no surgery. We report the immunological and clinical aspects of the long term survivors of this treatment.
D001500:BCG Vaccine / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007167:Immunotherapy; D007564:Japan; D009369:Neoplasms / Q000401:mortality / Q000628:therapy*
D001500:BCG Vaccine